Simeprevir (trade name: Olysio) is a medication used to treat chronic hepatitis C. It is a direct-acting antiviral drug, a protease inhibitor, which blocks a specific enzyme that the hepatitis C virus (HCV) uses to replicate itself. Simeprevir is used in combination with other antiviral medications and is taken once daily with food. It is prescribed to adults who have not been treated for HCV before, or those who have been treated with interferon-based therapy and not had success. Side effects may include fatigue, nausea, anemia, headache, and skin rash.
Simeprevir is an antiviral medication that was previously used to treat chronic hepatitis C infection, but it is no longer widely available. Here's a breakdown of its key aspects:
What it treats:
- Chronic hepatitis C caused by genotypes 1 or 4 of the Hepatitis C virus (HCV) [1, 2].
How it works:
- Simeprevir belongs to a class of drugs called HCV NS3/4A protease inhibitors [1, 2].
- It specifically inhibits an enzyme (NS3/4A protease) essential for the virus to mature and replicate [2, 3].
How it was used:
- Simeprevir was never used alone. It was part of a combination therapy regimen, typically with peginterferon alfa and ribavirin [1, 3].
- Treatment duration varied but often lasted around 12 weeks [3].
Important points to consider:
- Simeprevir is no longer a common treatment option due to the development of more effective and tolerable medications for hepatitis C [4, 5].
- It had potential side effects, including fatigue, headache, rash, and itchiness [3].
- It could interact with certain other medications [5].